Article -> Article Details
| Title | Global Peripherally Inserted Central Catheters Market to Reach USD 736 Million by 2031 |
|---|---|
| Category | Business --> Healthcare |
| Meta Keywords | Peripherally Inserted Central Catheters Market |
| Owner | shivani |
| Description | |
| Global Peripherally Inserted Central Catheters Market
to Reach USD 736 Million by 2031 | Growth Insights Global Peripherally Inserted
Central Catheters (PICC) market is witnessing sustained growth as
healthcare systems worldwide prioritize safer, longer-term vascular access
solutions for complex therapies. Valued at USD 516 million in 2024, the
market is projected to expand from USD 541 million in 2025 to USD 736 million
by 2031, advancing at a CAGR of 5.1% during the forecast period.
This steady rise reflects increasing demand for reliable intravenous access in
oncology, critical care, and home-based treatment settings. Read the complete
insights https://www.24lifesciences.com/peripherally-inserted-central-catheters-market-8377 Emerging
Healthcare Trends Driving the PICC Market In 2025, several healthcare trends
are reshaping the PICC market landscape. The growing shift toward outpatient
and home-based care models is significantly increasing the adoption of PICC
lines, which enable long-term therapies outside hospital settings. Advances in ultrasound-guided
insertion technologies are improving procedural safety and success rates,
while innovation in antimicrobial and antithrombotic coatings is
reducing infection and thrombosis risks. Together, these trends align with
global healthcare priorities focused on patient safety, efficiency, and cost
containment. Key
Market Drivers Supporting Industry Expansion
These drivers continue to position
PICCs as a preferred vascular access solution compared to traditional central
venous catheters. Download the full
market review https://www.24lifesciences.com/download-sample/8377/peripherally-inserted-central-catheters-market Competitive
Landscape: Leading PICC Manufacturers The Peripherally Inserted Central
Catheters market features established global players focused on safety
innovation, clinician training, and product differentiation. Key companies
profiled include:
These companies continue to expand
through R&D investments, product launches, and global market penetration
strategies. Segment
Insights & Regional Overview By type, valve-type PICCs
dominate the market due to their enhanced safety profile, reducing blood
backflow and air embolism risks, particularly in long-term therapies. By application,
adult patients account for the largest share, driven by aging
populations and high chronic disease prevalence, while pediatric applications
present specialized growth opportunities. In terms of end users, hospitals
remain the primary setting for PICC insertion and management, though home
care settings are emerging as a fast-growing segment. By material, polyurethane
catheters lead due to their balance of flexibility and durability, while advanced
coated materials are becoming key differentiators in premium offerings. Ultrasound-guided
insertion continues to set the standard of care, outperforming traditional
anatomical landmark techniques. Explore the full
findings https://www.24lifesciences.com/peripherally-inserted-central-catheters-market-8377 Regional Insights North America leads the PICC market,
supported by advanced healthcare infrastructure, strong reimbursement
frameworks, and high clinician awareness. Europe represents a mature and
regulated market with growing adoption of outpatient care models. Asia-Pacific
is the fastest-growing region, driven by healthcare expansion, rising chronic
disease burden, and increasing procedural expertise. South America and the
Middle East & Africa offer long-term growth potential, particularly in
private healthcare systems and advanced urban centers. Can
Advanced PICC Technologies Improve Long-Term Patient Outcomes? Ongoing innovation in catheter
coatings, navigation systems, and minimally invasive insertion techniques is
set to further improve patient outcomes and procedural efficiency. As
healthcare systems increasingly prioritize infection prevention and
decentralized care, advanced PICC solutions are expected to play a pivotal role
in future vascular access strategies. Key
Benefits of the 24LifeSciences PICC Market Report
Get the complete
data https://www.24lifesciences.com/peripherally-inserted-central-catheters-market-8377 Future
Perspective As global healthcare delivery
continues to evolve toward patient-centric and cost-efficient models, the Peripherally
Inserted Central Catheters market offers meaningful opportunities for
innovation and investment. Advances in materials, safety-focused design, and
insertion technologies are expected to sustain steady market growth and
reinforce the clinical value of PICCs across diverse care settings. Explore
Life sciences Related Ongoing Coverage in Healthcare Domain: Optical
Surgical Navigation Systems Market Chemotherapy
Induced Peripheral Neuropathy Treatment Market Hospital
Acquired Infection Treatment Market Fascial
Suture Instrument Market High
Speed Surgical Drill Market About 24lifesciences Founded in 2017, 24LifeScience has emerged as a trusted research and
analytics partner for organizations operating within the global life sciences
and chemical industries. Our core mission is to provide intelligent,
future-ready insights that help clients stay ahead in an increasingly complex
and innovation-driven market International: +1(332)
2424 294 | Asia: +91 9425150513 (Asia) Website: http://www.24lifesciences.com Follow us on LinkedIn: http://www.linkedin.com/company/lifesciences24 | |